Marco Prunotto Selected Research

Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)

9/2021	Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness.
1/2020	Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance.
1/2018	Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Prunotto Research Topics

Disease

10	Lupus Nephritis 03/2024 - 03/2010
9	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2024 - 03/2010
8	Neoplasms (Cancer) 12/2021 - 12/2009
6	Proteinuria 05/2023 - 01/2020
6	Fibrosis (Cirrhosis) 01/2023 - 01/2011
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022 - 01/2019
5	Glomerulonephritis 05/2023 - 03/2010
4	Hereditary Nephritis (Alport Syndrome) 01/2021 - 10/2014
4	Chronic Kidney Failure (Chronic Renal Failure) 10/2014 - 01/2011
3	Inflammation (Inflammations) 03/2024 - 01/2023
3	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021 - 05/2011
3	Kidney Diseases (Kidney Disease) 07/2021 - 03/2011
3	Rare Diseases (Rare Disease) 01/2020 - 12/2014
2	Rheumatoid Arthritis 12/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 07/2021 - 01/2020
2	Renal Insufficiency (Renal Failure) 06/2017 - 10/2014
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2023
1	Disease Progression 11/2022
1	Pathologic Processes 01/2022
1	Infections 12/2021
1	Amyloidosis 10/2021
1	7 Hereditary Prostate Cancer 09/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Albuminuria 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Microscopic Polyangiitis 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Cicatrix (Scar) 01/2019
1	Vasculitis (Vasculitides) 01/2019
1	Atherosclerosis 01/2018
1	Hypoxia (Hypoxemia) 12/2017
1	Hearing Loss (Hearing Impairment) 06/2017
1	Atrophy 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Mesothelioma 03/2016

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 03/2024 - 03/2010
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2010
7	Immunoglobulin G (IgG)IBA 11/2022 - 03/2010
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2011
6	CollagenIBA 09/2021 - 10/2014
4	AutoantibodiesIBA 03/2024 - 12/2020
4	Rituximab (Mabthera)FDA Link 01/2023 - 01/2020
4	Discoidin Domain Receptor 1IBA 09/2021 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2021 - 01/2018
3	AntigensIBA 12/2020 - 02/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023 - 01/2019
2	Deoxyribonucleases (DNase)FDA Link 10/2021 - 01/2021
2	Monoclonal AntibodiesIBA 10/2021 - 01/2020
2	SteroidsIBA 10/2021 - 01/2020
2	Prednisone (Sone)FDA LinkGeneric 10/2021 - 01/2020
2	AutoantigensIBA 12/2020 - 01/2019
2	Aldehyde Reductase (Aldose Reductase)IBA 12/2020 - 03/2010
2	Phosphopyruvate Hydratase (Enolase)IBA 12/2020 - 09/2011
2	Discoidin Domain ReceptorsIBA 11/2020 - 01/2020
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2017 - 10/2014
2	MesothelinIBA 03/2016 - 01/2016
2	Immunotoxins (Immunotoxin)IBA 03/2016 - 01/2016
2	LMB-100IBA 03/2016 - 01/2016
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 04/2012 - 02/2011
1	Complement System Proteins (Complement)IBA 05/2023
1	AntioxidantsIBA 05/2023
1	Myeloblastin (Proteinase 3)IBA 01/2023
1	ForminsIBA 11/2022
1	Annexin A1IBA 10/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	EnzymesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 10/2021
1	ofatumumab FDA Link 10/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 10/2021
1	Calcineurin InhibitorsIBA 10/2021
1	Carbonic Anhydrase IIIIBA 07/2021
1	Cystatin MIBA 07/2021
1	Ramipril (Altace)FDA LinkGeneric 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	CholesterolIBA 01/2021
1	Ezetimibe (Zetia)FDA Link 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	CreatinineIBA 01/2021
1	LipidsIBA 01/2021
1	ThrombospondinsIBA 12/2020
1	Phospholipase A2 ReceptorsIBA 12/2020
1	Fibrillar CollagensIBA 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Azathioprine (Imuran)FDA LinkGeneric 01/2020
1	OligonucleotidesIBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2020
1	IntegrinsIBA 11/2019
1	Tetradecanoylphorbol AcetateIBA 01/2019
1	Antisense OligonucleotidesIBA 01/2019
1	methionine sulfoxideIBA 01/2019
1	Bone Morphogenetic Protein 7IBA 12/2017
1	Oxygen (Dioxygen)IBA 12/2017
1	Dextrans (Dextran)FDA Link 11/2017
1	HydrogelsIBA 11/2017
1	Small Interfering RNA (siRNA)IBA 03/2016
1	Surface Antigens (Surface Antigen)IBA 03/2016

Therapy/Procedure

7	Therapeutics 01/2020 - 10/2012
1	Kidney Transplantation 01/2021
1	Lasers (Laser) 01/2019